FDA.reportPublic FDA data

OXALIPLATIN

Substance profile for UNII 04ZR38536J, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for OXALIPLATIN
Structure render from PubChem CID 9887054

Substance Identity#

UNII
04ZR38536J
Preferred term
OXALIPLATIN
Registry number
61825-94-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H14N2.C2O4.Pt
Chemical structure for OXALIPLATIN
Structure render from PubChem CID 9887054

Chemical And Database Identifiers#

InChIKey
ZROHGHOFXNOHSO-BNTLRKBRSA-L
SMILES
[Pt++].[O-]C(=O)C([O-])=O.N[C@@H]1CCCC[C@H]1N
RxCUI
32592
PubChem
9887054
NCIt
C1181
INN ID
6012

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound9887054https://pubchem.ncbi.nlm.nih.gov/compound/9887054
PubChem InChIKey SearchZROHGHOFXNOHSO-BNTLRKBRSA-Lhttps://pubchem.ncbi.nlm.nih.gov/#query=ZROHGHOFXNOHSO-BNTLRKBRSA-L
RxNorm32592https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=32592
NCI ThesaurusC1181https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1181
FDA Substance Registration System04ZR38536Jhttps://precision.fda.gov/uniisearch/srs/unii/04ZR38536J

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]12
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]12
oxaliplatinACTIVE MOIETY04ZR38536JELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC]10
oxaliplatinACTIVE INGREDIENT04ZR38536JELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [SANOFI-AVENTIS U.S. LLC]10
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTAVIS PHARMA, INC.]10
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTAVIS PHARMA, INC.]10
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC]10
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [FRESENIUS KABI USA, LLC]10
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [SUN PHARMA GLOBAL FZE]8
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [SUN PHARMA GLOBAL FZE]8
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]6
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]6
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE]5
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE]5
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]5
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]5
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION [SANDOZ INC]5
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION [SANDOZ INC]5
oxaliplatinACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]5
oxaliplatinACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]5
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [HOSPIRA WORLDWIDE, INC.]4
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [HOSPIRA WORLDWIDE, INC.]4
oxaliplatinACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS]3
oxaliplatinACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS]3
oxaliplatinACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
oxaliplatinACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
oxaliplatinACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]2
oxaliplatinACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [WINTHROP U.S.]2
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]2
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE OXALIPLATIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA WORLDWIDE, INC.]2
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN POWDER, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]2
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN POWDER, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]2
oxaliplatinACTIVE MOIETY04ZR38536JELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [AVENTIS PHARMA LTD.]1
oxaliplatinACTIVE INGREDIENT04ZR38536JELOXATIN (OXALIPLATIN) INJECTION, SOLUTION, CONCENTRATE [AVENTIS PHARMA LTD.]1
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN FOR INJECTION INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL INC.]1
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN FOR INJECTION INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL INC.]1
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC]1
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN INJECTION, SOLUTION, CONCENTRATE [APP PHARMACEUTICALS, LLC]1
OXALIPLATINACTIVE INGREDIENT04ZR38536JOXALIPLATIN POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1
OXALIPLATINACTIVE MOIETY04ZR38536JOXALIPLATIN POWDER, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1